About Time Cap Pharma Labs Private Limited
Data last updated: 22 February 2026
Time Cap Pharma Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 19 February 1988, the company has been in operation for over 38 years.
Registered with ROC Hyderabad under CIN U24232AP1988PTC008333.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹41.62 Lakh. Formerly known as Time Cap Pharma Labs Ltd and Time Cap Pharma Labs Pvt Ltd. It is led by directors including Venkata Satya Swathi Kantamani and Sadasiva Rao Nannapaneni.
Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Natco House Road No.2 Banjara Hills, Hyderabad, Telangana, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹165.03 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 2 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹3.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website natcopharma.co.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressNatco House Road No.2 Banjara Hills, Hyderabad, Telangana, India
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Time Cap Pharma Labs Private Limited
Time Cap Pharma Labs Private Limited has undergone 2 name changes throughout its history. The company was previously known as Time Cap Pharma Labs Ltd, and Time Cap Pharma Labs Pvt Ltd. The current legal name is Time Cap Pharma Labs Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Time Cap Pharma Labs Private Limited | Current |
| Time Cap Pharma Labs Ltd | Previous |
| Time Cap Pharma Labs Pvt Ltd | Previous |
CIN History of Time Cap Pharma Labs Private Limited
Time Cap Pharma Labs Private Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TG1988PTC008333, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG1988PTC008333 | Current |
| U24232AP1988PTC008333 | Previous |
| U24232AP1988PLC008333 | Previous |
| U99999AP1988PTC008333 | Previous |
| U24232TG1988PLC008333 | Previous |
Business Activity of Time Cap Pharma Labs Private Limited
Time Cap Pharma Labs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Time Cap Pharma Labs Private Limited
Time Cap Pharma Labs Private Limited is currently managed by 4 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Satya Swathi Kantamani | Whole-Time Director | 30 Sep 2024 | 1 Years 9 Months | Current |
|
Sadasiva Rao Nannapaneni
Also directs:
Natco Drug Discovery Private Limited, Ndl Infratech Private Limited, Natsoft Information Systems Private Limited and 2 more
|
Director | 30 Apr 2009 | 17 Years 2 Months | Current |
| Adinarayana Madineedi | Director | 31 Jan 2019 | 7 Years 5 Months | Current |
| Anand Babu Tummala | Director | 29 Apr 2000 | 26 Years 2 Months | Current |
Financials of Time Cap Pharma Labs Private Limited FY 2025 filings available
Time Cap Pharma Labs Private Limited reported revenue of ₹165.03 Cr (up 477% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Time Cap Pharma Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 1994 | Oriental Bank of Commerce | ₹1.4 Cr | Open |
| 28 Dec 1992 | Oriental Bank of Commerce | ₹1.68 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Time Cap Pharma Labs Private Limited
View historical data on people associated with Time Cap Pharma Labs Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Time Cap Pharma Labs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Time Cap Pharma Labs Private Limited
GSTIN & GST Filing Data of Time Cap Pharma Labs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Time Cap Pharma Labs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Time Cap Pharma Labs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Time Cap Pharma Labs Private Limited
MSME Payment Delays by Time Cap Pharma Labs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Time Cap Pharma Labs Private Limited
Subsidiaries & Group Companies of Time Cap Pharma Labs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Time Cap Pharma Labs Private Limited with ownership details.
MCA Filings & Documents of Time Cap Pharma Labs Private Limited
MCA Filings & Documents of Time Cap Pharma Labs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Time Cap Pharma Labs Private Limited
Recent News on Time Cap Pharma Labs Private Limited
Frequently Asked Questions about Time Cap Pharma Labs Private Limited
Time Cap Pharma Labs Private Limited is an active private limited company in the chemicals and materials sector based in Hyderabad, Telangana, India. It was incorporated on 19 February 1988 (38+ years old) and is registered under CIN U24232TG1988PTC008333. The company has 2 employees.
Time Cap Pharma Labs Private Limited reported revenue of ₹165.03 Cr for FY 2025 (up 477.00% YoY).
The current directors of Time Cap Pharma Labs Private Limited are:
The primary industry of Time Cap Pharma Labs Private Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Time Cap Pharma Labs Private Limited can be reached at the registered office: Natco House Road No.2 Banjara Hills, Hyderabad, Telangana, India, or through the website natcopharma.co.in.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹41.62 Lakh.